Amniotic Fluid Embolism and Pulmonary Embolism

  • Nidhi Patel
  • Ajesh Desai


Amniotic fluid embolism is a rare but potentially catastrophic condition. It occurs in response to amniotic fluid containing vernix and other solids entering the maternal circulation. Majority of the amniotic fluid occurs during labor. Maternal mortality and morbidity is high. It is the second most common cause of maternal death in developed countries. The commonest presentation of this condition is hypotension, respiratory distress, and coagulation failure. Most of the pregnant women will have cardiopulmonary arrest within first few minutes. Essential steps in the management include maintenance of oxygen, correction of hypotension, and treatment of coagulation failure.


Pulmonary Embolism Amniotic Fluid Unfractionated Heparin Uterine Artery Embolization Maternal Circulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Arterial blood gas analysis


Amniotic fluid embolism


Adult respiratory distress syndrome


Complete blood count


Cardiothoracic pulmonary angiography


Chest X-ray


Disseminated intravascular coagulation


Fresh frozen plasma


High dependency unit


Pulmonary embolism


  1. 1.
    South Australian perinatal practice guidelines. Department of Health, Government of South Africa. Available from Scholar
  2. 2.
    Clark SL, Hankins GDV, Dudley DA, Dildy GA, Flint Porter T. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995;172:1158–69.CrossRefPubMedGoogle Scholar
  3. 3.
    Moore LE, Smith CV. Amniotic fluid embolism treatment and management. Emedicine Medscape [serial online] 2009 Dec [cited 2011 May 17].Google Scholar
  4. 4.
    acog May 28 2014 draft guideline.Google Scholar
  5. 5.
    Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J, et al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth. 2012;12:7.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ. Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol. 2010;115(5):910–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 2008;199(1):49 e1–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Tuffnell DJ. United Kingdom amniotic fluid embolism register. BJOG. 2005;112(12):1625–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Gilbert WM, Danielsen B. Amniotic fluid embolism: decreased mortality in a population-based study. Obstet Gynecol. 1999;93(6):973–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995;172(4 Pt 1):1158–67.CrossRefPubMedGoogle Scholar
  11. 11.
    Burrows A, Khoo SK. The amniotic fluid embolism syndrome: 10 years’ experience at a major teaching hospital. Aust N Z J Obstet Gynaecol. 1995;35(3):245–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Morgan M. Amniotic fluid embolism. Anaesthesia. 1979;34(1):20–32.Google Scholar
  13. 13.
    RCOG 2011 guidelines. Available from Scholar
  14. 14.
    Roberts CL, Algert CS, Knight M, Morris JM. Amniotic fluid embolism in an Australian population-based cohort. BJOG. 2010;117:1417–21.CrossRefPubMedGoogle Scholar
  15. 15.
    Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118 Suppl 1:1–203. Available from URL: 10.1111/j.1471- 0528.2010.02847.x/pdf.Google Scholar
  16. 16.
    Perozzi KJ, Englert NC. Amniotic fluid embolism: an obstetric emergency. Crit Care Nurse. 2004;24:54.PubMedGoogle Scholar
  17. 17.
    Goldszmidt E, Davies S. Two cases of hemorrhage secondary to amniotic fluid embolus managed with uterine artery embolization. Can J Anaesth. 2003;50(9):917–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Koonin LM, Atrash HK, Lawson HW, Smith JC. Maternal mortality surveillance, United States, 1979–1986. MMWR CDC Surveill Summ. 1991;40(SS-2):1–13.PubMedGoogle Scholar
  19. 19.
    Lewis G, Drife J, Botting B, et al. Report on confidential enquiries into maternal deaths in the United Kingdom 1994–96. HMSO. 1998.Google Scholar
  20. 20.
    NIH. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA. 1986;256:744–9.CrossRefGoogle Scholar
  21. 21.
    de Swiet M, Fidler J, Howell R, Letsky E. Thromboembolism in pregnancy. In: Jewell D, editor. Advanced medicine, vol. 80. London: Pitman Medical; 1981. p. 309–17.Google Scholar
  22. 22.
    Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J. 1996;41:83–6.PubMedGoogle Scholar
  23. 23.
    Rutherford S, Montoro M, McGehee W, Strong T. Thromboembolic disease associated with pregnancy: an 11 year review. Am J Obstet Gynecol. 1991;164(Suppl):286.Google Scholar
  24. 24.
    Ginsberg JS, Brill-Edwards P, Burrows RF, et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost. 1992;67:519–20.PubMedGoogle Scholar
  25. 25.
    Department of Health and Social Security. Report on confidential enquiries into maternal deaths in England and Wales 1973–5. London: HMSO; 1979.Google Scholar
  26. 26.
    Department of Health. Report on confidential enquiries into maternal deaths in the United Kingdom 1988–90. London: HMSO; 1994.Google Scholar
  27. 27.
    de Swiet M. Thromboembolism. In: de Swiet M, editor. Medical disorders in obstetric practice. 3rd ed. Oxford: Blackwell Scientific Publications; 1995. p. 116–42.Google Scholar
  28. 28.
    Carr MH, Towers CV, Eastenson AR, Pircon RA, Iriye BK, Adashek JA. Prolonged bed rest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? J Matern Fetal Med. 1997;6:264–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Hirsch DR, Mikkola KM, Marks PW, et al. Pulmonary embolism and deep vein thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J. 1996;131:1145–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost. 1989;61:189–96.PubMedGoogle Scholar
  31. 31.
    British Thoracic Society Standards of Care Committee. Thorax. 1997;52 Suppl 4:S1–24.Google Scholar
  32. 32.
    Miniati M, Pistolesi M, Marini C, et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED). Am J Respir Crit Care Med. 1996;154:1387–93.CrossRefPubMedGoogle Scholar
  33. 33.
    Miniati M, Monti S, Pratali L, et al. Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: results of a prospective study in unselected patients. Am J Med. 2001;110:528–35.CrossRefPubMedGoogle Scholar
  34. 34.
    Chuu WM, Wang NY, Perry D. Vena caval filters for the prevention of pulmonary embolism. N Engl J Med. 1998;339:46–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Dahlman T, Lindvall N, Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol. 1990;97:221–8. 1384 M. de Swiet Eur Heart J, Vol. 20, issue 19, September 1999.CrossRefPubMedGoogle Scholar
  36. 36.
    Dahlman TC, Hellgren MS, Blomback M. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. Am J Obstet Gynecol. 1989;161:420–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–15.CrossRefPubMedGoogle Scholar
  38. 38.
    Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 1995;108(Suppl):305S–11.CrossRefPubMedGoogle Scholar
  39. 39.
    Greenfield J, Proctor MC. Role of catheter embolectomy in treating pulmonary embolism. Semin Respir Crit Care Med. 1996;17:71–85.CrossRefGoogle Scholar
  40. 40.
    Greenfield LJ, Cho KJ, Proctor MC, Sobel M, Shah S, Wingo J. Late results of suprarenal Greenfield vena cava filter placement. Arch Surg. 1992;127:969–73.CrossRefPubMedGoogle Scholar
  41. 41.
    Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122–40.CrossRefPubMedGoogle Scholar
  42. 42.
    Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation. 1996;93:2212–45.CrossRefPubMedGoogle Scholar
  43. 43.
    Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol. 1993;46:489–96.CrossRefGoogle Scholar
  44. 44.
    Nelson Piercy C, Letsky EA, de Swiet M. Low molecular weight heparin for obstetric thromboprophylaxis: experience of 69 pregnancies in 61 women at high risk. Am J Obstet Gynecol. 1997;176:1062–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Ojukwu C, Jenkinson SD, Obeid D. Deep vein thrombosis in pregnancy and heparin hypersensitivity. Br J Obstet Gynaecol. 1996;103:934–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Omri A, Delaloye JF, Andersen H, Bachmann F. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost. 1989;61:55–6.PubMedGoogle Scholar
  47. 47.
    Orme ML, Lewis PJ, de Swiet M, et al. May mothers given warfarin breast-feed their infants? BMJ. 1997;1:1564–5.CrossRefGoogle Scholar
  48. 48.
    Savage P, Roddie M, Seckl. A 28-year-old woman with pulmonary embolus. Lancet. 1998;352:30–1.CrossRefPubMedGoogle Scholar
  49. 49.
    Tan J, de Swiet M. Use of aspirin for obstetric thromboprophylaxis in low risk women. J Obstet Gynaecol. 1998;18 Suppl 1:S46–7.Google Scholar
  50. 50.
    Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med. 1996;335:108–14.CrossRefPubMedGoogle Scholar
  51. 51.
    Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv. 1995;50:534–41.CrossRefPubMedGoogle Scholar
  52. 52.
    Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Lewandowski B. SimpliRED D-Dimer can reduce the diagnostic tests in suspected deep vein thrombosis. Lancet. 1998;351:1405–6.CrossRefPubMedGoogle Scholar
  53. 53.
    Baddarraco MA, Vessey MP. Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J. 1974;1:215–7.CrossRefGoogle Scholar
  54. 54.
    Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—111: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J. 1994;308:235–46.CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Obstetrics & Gynaecology DepartmentGMERS Medical CollegeAhmedabadIndia

Personalised recommendations